Posts Tagged ‘Melanoma’

On Common Ground: Applying “Open Source” to Cure Melanoma

Tuesday, January 18th, 2011

Most doctors feel for their patients and we empathize with the challenges of their illness.  We work to the best of our experience and understanding to find cures, solutions, or sometimes just more comfort.  But when it comes to big challenges, such as advancing treatment options for diseases like Melanoma, sometimes empathy is not enough.  Sometimes what sparks the motivation to find solutions or cures is personal experience….

That is what spurred e-commerce entrepreneur, Marty Tennenbaum.  While he’s not a doctor or even medical researcher, he does know his way around computers, and the value of “open source” as a route to developing solutions.  So, after surviving Melanoma in the late ’90s he begin applying his expertise to help move the needle on treatment solutions.

Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are fragmented — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close.

Marty recognized that dilemma and his doing his part to use his tech know-how to bring about a tool to help solve that problem:  An app.

Dr. Marty Tenenbaum, a survivor of melanoma, shows off his free Cancer Commons app

Dr. Marty Tenenbaum, a survivor of melanoma, shows off his free Cancer Commons app

Launching today (1/18/11), the “Cancer Commons” app will integrate existing data about melanomas, and cross reference promising experimental treatments.   Then, patients or doctors can in put patient-specific info on the progression of the disease including test results, such as specific genetic mutations.

“From that information, the app tells patients what specific cancer “subtype” they have as determined by an expert panel. They also learn what drugs have shown the most promise in treating that specific form of the disease and where clinical trials are being conducted that could allow patients access to that treatment.”

Marty explains that he’s just “trying to pull together all the pieces that are needed to do a real, rational attack on cancer.”

…’The way to do that,’ he says, ‘is to pull people out of their individual labs, offices and hospitals to collaborate in a way not possible before the Web and mobile technologies made it easy to pool vast amounts of information.

‘How much of cancer could be turned into a manageable disease if we only knew what we knew?’”

It’s a challenge to wrap our arms around the collected knowledge of thousands of researchers.  Groups like Health Commons and Open Science are taking a page from today’s socially networked world to tap that trust and are working to throw open the doors to the brain trust.  MoleSafe and Melanoma Updates applauds this approach, and gives Marty Tennenbaum and the collected participants pitching in a big Hat’s On Award to helping shine the light on the way to a cure for Melanoma and other cancers.

Share

Looking Back with Pride; Looking Forward with Hope

Friday, December 31st, 2010

This update is just a thank you to all our friends and patients of MoleSafe and readers of MelanomaUpdates.com, and warm wishes for a heavenly Twenty-Eleven.  As we face a new year lots of us like to reflect on what occurred and what we hope the next year may bring.  This time last year we announced our alignment with the Charles C. Harris Skin and Cancer Unit at NYU’s world-renowned Langone Medical Center – the first major hospital in the United States to partner with and adopt the MoleSafe methodology. As you may know, the approach we use is the “gold standard” of skin cancer detection in high occurence countries such as New Zealand and Australia, having the prestigious NYU Medical Center implement the MoleSafe method was a wonderful way to start 2010.

Now, with six clinic locations in the United States – from Albuquerque to Savannah, it is hugely satisfying to know that we’ve helped thousands find peace of mind about an area of concern, or even prolonged or saved some lives via early detection of Melanoma.  And skim through our other past blog posts this past year and it’s clear the word about best practices in detection and skin cancer prevention is getting out there more and more.  Yet my wish for the New Year is to offer peace of mind and good health to thousands more, from all of us at MoleSafe around the country, as we continue to fight the good fight.

Thank you for sharing this blog with your friends and family — and for remembering that the new year is a good time to renew a commitment to regular skin cancer check ups!

Share

Detecting Melanoma in the land of Dr. Oz

Sunday, November 21st, 2010

To his credit, Dr Mehmet Oz’s web site features some 1600+ comments resulting from a search on the topic of Melanoma, including an array of videos.  We’re launching a “Hat’s On” salute (get it? sun protection vs Hat’s Off?!) from MoleSafe and Melanoma Updates to those doing a good job creating more awareness and quality information on preventing and treating skin cancers.

So, our first Hat’s On Award goes to Dr Oz, for his very informative, and sometimes in-your-face real, series of answers and show segments on this disease.

In this example, he shows off the mole of an audience member to explain the ABCDEs of self-exams. In another more startling audience experience he shows a real tissue sample of the effects of skin cancer.

Dr Oz Showing Skin Cancer Tissue Sample

Dr Oz Showing Skin Cancer Tissue Sample

Even his fans have picked up the gauntlet: here’s a written summary of the above skin cancer prevention show in this blog excerpt created by “DrOzFans.com”:

Dr Oz: How to Avoid Skin Cancer

The Dr Oz Cancer Proof Your Life show including a segment on the number one cancer you can avoid – Skin Cancer.  Over 1 million Americans are diagnosed with Skin Cancer and almost 1 person every hour dies from it.  Doctor Oz said that Skin Cancer is preventable.  A Melanoma usually has pigment, but it does not have to have a color to be dangerous.   He showed a sample of a real Skin Cancer that looked very rough and scaly on the surface.

Here is Dr Oz’s list of true / false questions about Skin Cancer.  See how many you get right!

1.  If you live in North Dakota & use sunscreen, your risk of Melanoma may be greater than someone in South Florida?

Dr Oz said that this is true because people in North Dakota have a higher risk for Skin Cancer for two reasons.  One reason is that there is less ozone in North Dakota than in Florida, so the UV rays can get through more easily.  The second reason is that Vitamin D helps to prevent Skin Cancer, and Northerners tend to be low in Vitamin D.  So Dr Oz suggested taking vitamin D supplements or you can be in the sun for only 15 minutes a day, and after that you must apply sunscreen.  Dr Oz said that the right amount of sunscreen to apply is the amount that would fill up a shot glass (1.5 ounces).

2. The Color of Your Clothes Can Protect You From Skin Cancer?

True!  Dr Oz said that different colors of clothes do protect you from the sun better.  For example, red or blue fabrics are harder for the rays to get through, whereas white or yellow clothing puts you at a greater risk.  This past summer I noticed a trend in companies offering clothing with built in sunscreen, which also seems like a great option.  Dr Oz said that your face is very prone to getting Skin Cancer, and it is twice as likely to kill you if you get it there, so make sure to cover your head with a hat too.

3.  Pedicures Increase Your risk of Skin Cancer?  Dr Oz Pedicures Cause Skin Cancer

Dr Oz said that it is true that Pedicures increase your chances of getting Skin Cancer.  You must remove nail polish at least once a month to make sure nothing is growing underneath your nail.  Also, the UV light used in nail drying machines may cause cancer, so either ask your nail technician to turn off the UV light or just let your nails air dry.

Share

Not Fare

Monday, November 15th, 2010

Whether it is the news of a high profile person dying of Melanoma, such as Stephen J. Cannell, or shows like Showtime’s The Big C being based on a patient terminally ill with the disease — or even the vampire-chic pale skin, it’s good to see media trending towards the no-tan-zone.  So, maybe my world and my reading is a little cancer-centric, but I still found it surprising to see this ad from Jet Blue:

jet blue

I’m sure Jet Blue is a fine airline, but I’d prefer they find another way to encourage fliers.  Tanning, even for free, is not worth the trip.

Share

Getting Updated on Melanoma

Monday, October 25th, 2010

Having just returned from AdvaMed2010 with some 1,500 others also involved in diagnostics and effective treatments, certainly education and medical progress is top of mind. So, it’s appropriate that the Skin Cancer Foundation’s 4th edition of the handbook, “Understanding Melanoma – What you Need to Know” came out this week.

melanomabookThe 91-page guide runs through all aspects of the disease:

“from the moment of diagnosis through state- of-the-art treatments. Honest and straightforward, but reassuring in tone. Contrary to what many people fear, there is an excellent chance for a long and healthy life after diagnosis. Early warning signs and a step-by-step illustrated guide to self- examination of the skin are presented along with answers to the 25 questions most frequently asked about melanoma.”

(Note: It may be easier to get a copy on the SkinCancer.org store directly as it was already sold out on Amazon.com.)

And, my education continued, as mentioned, at AdvaMed, which was a terrific conference, even beyond appreciating both Katie Couric as a general session speaker and the ice cream social! Since MoleSafe has made such strides in sharing the exam and results with diagnostic experts and referring physicians through digital technologies like our proprietary View software, I was particularly interested in the panel on doctors using remote monitoring and real-time communication using mobile interfaces. These are very exciting times.

And, being advocates for awareness and prevention, I was pleased to see the session on “Diagnostics: The Cornerstone of Comprehensive Patient Care” well-attended. The key takeaways there were that diagnostics can enable a more efficient and effective healthcare system; second, and diagnostics can change the focus of healthcare from treating sickness to promoting wellness. Here here! (And, hopefully that “here” will include MoleSafe’s 6 locations!)

Keep educating, and help us keep the buzz about the need for skin cancer early detection going strong.

Share

Indiscriminate Melanoma

Wednesday, October 13th, 2010

Stephen J Cannell passed away in early October at the age of 69, due to complications from Melanoma. The creator of “The Rockford Files” and “The A Team,” Cannell produced more than 40 TV series including “Baretta,” “21 Jump Street,” and “Wiseguy.” Certainly his loved ones will suffer the loss as much as any who lose a family member or friend. But when a high-profile personality falls victim to Melanoma it does help raise awareness and the point that this is not a disease that can easily be won even with access to the most expensive of doctors and treatments.

It is an equal opportunity assailant.

The good news is the money IS being well spent in research and seems to be starting to pay off. As I wrote about Bob Marley and other celebrities who have suffered and lost to Melanoma, vigilance is key, no matter your walk of life. Regular screenings at MoleSafe can SAVE LIVES via earlier diagnoses. In addition, as requested by the producer’s family, you may choose to honor someone with a donation to the American Cancer Society …or the Melanoma Research Foundation or the other organizations they list who are also doing excellent research towards finding better treatments and hopefully a cure:

If you know others doing great work, please share!

Share

Columbus Day brings Fundraising for Melanoma discoveries

Friday, October 1st, 2010

There is a lot of good team effort taking place throughout the year and throughout the country to raise money for Melanoma research. With the upcoming celebration of Columbus — one brave explorer — I wanted to take a moment to point out just some of the many support-worthy events that are taking place to help fund more discoveries by other brave explorers in science:

10/3/10: Miles for Melanoma: The Dermatology Interest Group at the University of Minnesota is running Twin Cities Marathon on October 3rd, 2010. You can also Like their Facebook Fan Page and learn more about TeamM4M.

10/7/10: Wings of Hope for Melanoma – Melanoma Research Foundation’s Annual Fundraising Gala
6:00 PM to 10:00 PM. Includes samplings from NYC restaurants and spirit companies, music, silent and live auctions, and an elaborate sweepstakes.
Edison Ballroom
New York, New York

10/9/10: TeamM4M from ING runs the Hartford, CT Marathon.

And training continues for TeamM4M to run the:

  • Rock ‘n’ Roll Denver Marathon and Half Marathon on October 17th
  • Marine Corps Marathon in Washington, DC on October 31st

10/10/10: More efforts to support -

More can be found on the Special Events Calendar at Melanoma.org, as well as many other sites, such as the Melanoma Foundation of New England. And, many teams, including one with Shonda Schilling and the Shade Foundation, are signing up to run the 11/7/10 ING New York Marathon for fundraising.

Thanks to all those walking, running, and fundraising to help the good fight. With the recent promising news in drug research we may be seeing some impact from everyone’s collected effort. Let’s all keep up the good work and spread the news and the contributions!

Share

One Patient’s Goal: Raise Melanoma Awareness

Tuesday, September 21st, 2010

As you may know, MoleSafe’s origins are from MoleMap, which has gained a position as the “gold standard” for melanoma screenings in countries with some of the highest occurrence of the disease: New Zealand and Australia. It doesn’t matter where one lives, as the sun warms our planet everywhere…but some are more exposed more intensively.

Story of Melanoma patient's fight for life, and to raise awareness.

Story of Melanoma patient's fight for life, and to raise awareness.

So we bring you this journey of Alan Lewis, from 3News. Alan, a record-setting speed boat racer, is a melanoma patient from New Zealand and now in a race for his life. He’s making it his mission to shine a worldwide light on the need for early detection of skin cancer by allowing a series of videos to follow his fight. Though his situation is dire, we thank him for his candor and bravery and by sharing it here hope to help that goal.

In the video, Alan mentions the challenge of a self-skin exam. As we suggested in a post from February, a great way to “love the one you’re with” is a mutual skin exam as a first line of defense. But best practices? Book your own thorough screening at a MoleSafe location today.

Share

One Patient's Goal: Raise Melanoma Awareness

Tuesday, September 21st, 2010

As you may know, MoleSafe’s origins are from MoleMap, which has gained a position as the “gold standard” for melanoma screenings in countries with some of the highest occurrence of the disease:  New Zealand and Australia.  It doesn’t matter where one lives, as the sun warms our planet everywhere…but some are more exposed more intensively.

Story of Melanoma patient's fight for life, and to raise awareness.

Story of Melanoma patient's fight for life, and to raise awareness.

So we bring you this journey of Alan Lewis, from 3News. Alan, a record-setting speed boat racer, is a melanoma patient from New Zealand and now in a race for his life.  He’s making it his mission to shine a worldwide light on the need for early detection of skin cancer by allowing a series of videos to follow his fight. Though his situation is dire, we thank him for his candor and bravery and by sharing it here hope to help that goal.

In the video, Alan mentions the challenge of a self-skin exam. As we suggested in a post from February, a great way to “love the one you’re with” is a mutual skin exam as a first line of defense. But best practices? Book your own thorough screening at a MoleSafe location today.

Share

Deciphering Treatment News for Melanoma

Tuesday, September 14th, 2010

The past couple of months, some compelling new stories have circulated about promising Melanoma treatments. In June, you read about “ipi” – in the news and here on Melanoma Updates. And, this past month, more news touted early clinical trials with another targeted therapy drug, PLX4032. As always, we are cautiously optimistic, but to shed some light on two exciting, but still emerging options, I thought a basic overview might be helpful.

So, what do these drugs do? Quite simply, one attacks a gene mutation found in about 50% of all melanoma patients. And one works to modulate the immune system.

Ipi for Immunity

Ipi is an immune therapy drug: it tries to activate or stimulate the immune system to clear cancer cells. With the usual current immuno-therapy treatments, such as interleukin, we haven’t been able to significantly extend the immune response to melanoma cells. But Ipi has been shown to extend that immune protection for longer and longer time spans, for the first time ever, leading to 2-year survival rates in around 56% of a certain group of patients (again, with advanced melanoma survival rates typically not extending past 10 months.) Ipi has been in advanced trials for years, and the very promising Phase III results spurred the recent media frenzy. As such, it is on the fast track for priority approval – perhaps as soon as the end of this year – and may become the first new melanoma drug approved in decades.

Gene Mutation Therapy

First, it’s important to know that about half of patients with metastatic melanoma have a mutation in a gene called BRAF. This is a gene that seems to program the “runaway cell division that is a hallmark of cancer.” When the impact of the BRAF gene mutation was established, scientists set to work to find a way to switch it off or slow down the programming to cells, and one of those ways may be an exciting new gene therapy drug, PLX4032 (no catchy name as of yet.) A remarkable 81% of cases showed marked and in many cases immediate improvement and reduction in tumor size and growth. Granted, the news came after just a small Phase I clinical trial, but there was such excitement about the results that in a rare move, the drug has skipped Phase II and is now being tested in longer term and wider scope Phase III trials.

As reported in USA Today:

No other drug has ever helped that high a percentage of patients with melanoma or any other solid tumor, says Paul Chapman, co-author of the study in today’s New England Journal of Medicine. The results are especially striking, he says, considering that only 10% to 20% of patients respond to standard treatments for melanoma, which don’t improve overall survival.

USA Today also has a sidebar Q&A piece that does a nice job of summarizing the caution and optomisim surrounding PLX4032. They include a phone number for more information about it as well: 888-662-6728.

A One-Two Punch?

Since the back to back encouraging news broke for ipi and PLX4032, some are combining the two in other drug therapy trials. Here is a quote from the National Cancer Institute Bulletin this past week:

In June, researchers announced that ipilimumab, a treatment that targets the immune system, helped patients with advanced melanoma live longer. Together, ipilimumab and PLX4032 have changed the landscape of melanoma research and raised the prospect that the new agents could be tested in combination or sequentially, said Dr. Claudio Dansky Ullmann, who oversees melanoma trials for the NCI Cancer Therapy Evaluation Program.

"These studies have opened the doors to a lot of possibilities for treating metastatic melanoma,” said Dr. Dansky Ullmann. "We can now test many treatments that were not available or proven until recently. This area of research is taking off.”

Share